SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bambusa Therapeutics Sees IPO of 9,375,000 Common Shares

Bambusa Therapeutics sees an initial public offering of 9,375,000 common shares, according to an SEC filing.

Related stories